No... CalMustang and I have been in TRVN for awhile now. I sold some covered calls in AMRN right after 3/30 to try and make up a little cash I lost in that debacle.
Used the money to buy the $2.50 September Calls.
Those Calls are in my Roth. I have a few shares and some more Calls in my cash account. But less than what's on my Roth.
We're all hoping Pfizer reaches in there wallet and plops down $2 billion for Trevena. With TRV027 potential and rest of pipeline it would be a drop in the bucket for them. But would put TRVN's PPS just under $20/share.
Market Data 
Markets 
AI
